On November 1, 2022 Alligator Bioscience (Nasdaq Stockholm: ATORX) reported that senior company representatives will participate in the following scientific and industry conferences during November and December 2022 (Press release, Alligator Bioscience, NOV 1, 2022, View Source [SID1234622665]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Festival of Biologics, November 2 – 4, Basel, Switzerland
Mattias Levin, PhD, Senior Team Manager, Antibody Engineering, at Alligator Bioscience, will give a presentation entitled "Neo-X-Prime: Bispecific Tumor Antigen Conditional CD40 Agonistic Antibodies" at 5:00 pm CET on November 3.
Registration for the conference is open here.
Society for Immunotherapy of Cancer (SITC) (Free SITC Whitepaper) 37th Annual Meeting, November 8 – 12, Boston, United States
Malin Lindstedt, visiting professor at Alligator Bioscience and Professor at the Department of Immunotechnology at Lund University, will give a poster presentation entitled "Early pharmacodynamic changes measured by RNA sequencing in peripheral blood from patients in a phase 1 study with mitazalimab, a potent CD40 agonistic IgG1 monoclonal antibody", poster number 35, on November 10.
Ana Carneiro, Associate Professor and Consultant at Lund University, will give a poster presentation entitled "ATOR-1017, a 4-1BB antibody, demonstrates promising safety and proof of mechanism in a first-in-human study in patients with advanced solid malignancies", poster number 714, on November 11.
Registration for the conference is open here.
Jefferies 2022 London Healthcare Conference, November 15 – 17, London, United Kingdom
Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will attend in person to meet investors.
Redeye Life Science Day, November 24, Stockholm, Sweden
Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will present the company, its latest developments, and upcoming catalysts to investors.
Biostock Life Science Fall Summit 2022, November 29-30, Lund, Sweden
Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will give a corporate presentation followed by a Q&A session at 1:00 pm CET on November 30.
More information about the conference can be viewed here.
13th Annual DNB Nordic Healthcare Conference, December 15, Oslo, Norway
Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will present the company, its latest developments, and upcoming catalysts to investors.
The information was submitted for publication, through the agency of the contact person set out above, at 8:30 a.m. CET on November 1, 2022.